Postherpetic neuralgia
Drug research and approvals for postherpetic neuralgia: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.
As of Nov 21, 2026, 15 studies of postherpetic neuralgia are recruiting on ClinicalTrials.gov, Health Canada has authorized 0 drug trials for it since 2013, and FDA has 4 approved and 12 open orphan designations naming it.
- Recruiting worldwide: 15
- Trials authorized in Canada: 0
- FDA orphan approvals: 4
- EU medicines: 0
- A Clinical Trial to Evaluate the Efficacy and Safety of HL-1186 Tablet in the Treatment of Postherpetic NeuralgiaNCT07758920 · Phase 2 · Shanghai Yidian Pharmaceutical Technology Development Co., Ltd. · starts Aug 1, 2026
- Extended-release Pregabalin for the Treatment of Neuropathic Pain in Patients With Diabetic Peripheral Neuropathy and…NCT07712913 · Phase 3 · Brainfarma Industria Química e Farmacêutica S/A · starts Jun 18, 2026
- Intradermal Exosomes, Platelet-Rich Plasma, and Steroids for Post-Herpetic NeuralgiaNCT07565844 · Not applicable · Zagazig University · starts Feb 2, 2025
- Erector Spinae Plane Block Versus Transcutaneous Radiofrequency in Postherpetic NeuralgiaNCT07400640 · Not reported · Diskapi Teaching and Research Hospital · starts Jun 1, 2025
- Efficacy of Transcutaneous Pulsed Radiofrequency in Postherpetic NeuralgiaNCT07390279 · Not reported · Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization · starts Feb 1, 2026
- The Analgesic Efficacy and Safety of Venlafaxine for Prevention of Postherpetic Neuralgia in Patients With Acute Herpes…NCT07361796 · Not applicable · Beijing Tiantan Hospital · starts Dec 15, 2025
- Y-4 to Treat the Postherpetic NeuralgiaNCT07275762 · Phase 2 · Neurodawn Pharmaceutical Co., Ltd. · starts Feb 2, 2026
- Comparison Between the Efficacy of Ultrasound-guided Erector Spinae Plane Block and Conventional Treatment for Pain…NCT07256145 · Not applicable · Alexandria University · starts Aug 1, 2025
- The Effectiveness of Ultra-Sound Guided Erector Spinae Block With Betamethasone for Management of Truncal Chronic Post…NCT07000409 · Not applicable · Cairo University · starts May 1, 2025
Approved 3
- LidocaineSodium channel alpha subunit blocker
- GabapentinVoltage-gated calcium channel modulator
- Gabapentin enacarbilVoltage-gated calcium channel modulator
Phase 3 5
- PregabalinVoltage-gated calcium channel modulator
- MethadoneMu opioid receptor agonist
- RemifentanilMu opioid receptor agonist
- MirogabalinVoltage-gated calcium channel alpha2/delta subunit 1 modulator
- Crisugabalin
Phase 2 12 of 26
- LacosamideSodium channel alpha subunit blocker
- OlodanriganAngiotensin II type 2 (AT-2) receptor antagonist
- ZucapsaicinVanilloid receptor agonist
- T-62Adenosine A1 receptor modulator
- Senrebotase
- Funapide
- EzogabineKCNQ (Kv7) potassium channel opener
- LamotrigineSodium channel alpha subunit blocker
- OnabotulinumtoxinaSynaptosomal nerve-associated protein 25 (SNAP-25) inhibitor
- SorivudineDNA polymerase catalytic subunit inhibitor
- LevetiracetamSynaptic vesicle glycoprotein 2A modulator
- CapsaicinVanilloid receptor opener
Phase 1 or earlier 3
- BupivacaineSodium channel protein type IV alpha subunit blocker
- AspirinCyclooxygenase inhibitor
- Mannitol
How its trials ended
168 ClinicalTrials.gov studies of the condition, classified by TrialPanorama, partly automatically, so some labels are wrongOf the 55 whose ending is known, 55% met their primary endpoint, 7% missed it and 38% stopped early.
- Completed, result not reported8048%
- Met its primary endpoint3018%
- Stopped: other or unclear1710%
- Status unknown1710%
- Ongoing1610%
- Missed its primary endpoint42%
- Stopped: enrollment or feasibility32%
- Stopped: sponsor or business decision11%
| Jun 6, 2012 | HorizantManagement of postherpetic neuralgia in adults. | Arbor Pharmaceuticals, LLC | Approved |
| Jan 28, 2011 | GraliseFor the management of postherpetic neuralgia | Golf Acquiror LLC | Approved |
| Nov 16, 2009 | QutenzaManagement of neuropathic pain associated with postherpetic neuralgia | Averitas Pharma, Inc. | Approved |
| Mar 19, 1999 | Lidoderm PatchFor relief of allodynia (painful hypersensitivity), and chronic pain in postherpetic neuralgia. | Teikoku Pharma USA, Inc. | Approved |
| Jun 2, 2016 | D-methadoneTreatment of postherpetic neuralgia | Levomecor Inc. | Designated |
| May 31, 2016 | Bupivacaine hydrochlorideTreatment of pain associated with postherpetic neuralgia. | Grace Therapeutics, Inc. | Designated |
| Feb 23, 2015 | NaltrexoneTreatment of postherpetic neuralgia | Allodynic Therapeutics LLC | Designated |
| Apr 14, 2014 | naltrexone/clonidine combinationTreatment of postherpetic neuralgia | Allodynic Therapeutics LLC | Designated |
| Jan 19, 2010 | Amitriptyline and ketamineTreatment of postherpetic neuralgia | Immune Pharmaceuicals, Inc. | Designated |
| Feb 17, 2009 | CivamideTreatment of postherpetic neuralgia. | Winston Laboratories, Inc. | Designated |
| Jun 18, 2008 | BupivacaineRelief of persistent pain associated with postherpetic neuralgia | DURECT Corporation | Designated |
| Jan 8, 2007 | MepivacaineTreatment of postherpetic neuralgia | Relmada Therapeutics, Inc. | Designated |
| Aug 3, 2005 | CapsaicinTreatment of postherpetic neuralgia. | TheraQuest Biosciences, LLC | Designated |
| Jul 8, 2005 | AlfentanilManagement of postherpetic neuralgia | Cinergen, LLC | Designated |
| Apr 26, 2005 | Tramadol hydrochlorideManagement of postherpetic neuralgia | TheraQuest Biosciences, LLC | Designated |
Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA